J. Ember, M. Jagels, and T. Hugli, Characterization of complement anaphylatoxins and their biological responses. Edited by: Volanakis JE, Frank MM. The Human Complement System in Health and Disease, pp.241-284, 1998.

B. Morgan and P. Gasque, Expression of complement in the brain: role in health and disease, Immunology Today, vol.17, issue.10, pp.461-466, 1996.
DOI : 10.1016/0167-5699(96)20028-F

F. Sellebjerg, I. Jaliashvili, M. Christiansen, and P. Garred, Intrathecal activation of the complement system and disability in multiple sclerosis, Journal of the Neurological Sciences, vol.157, issue.2, pp.168-174, 1998.
DOI : 10.1016/S0022-510X(98)00086-0

A. Tenner, Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events, Neurobiology of Aging, vol.22, issue.6, pp.849-861, 2001.
DOI : 10.1016/S0197-4580(01)00301-3

Y. Barde, Trophic factors and neuronal survival, Neuron, vol.2, issue.6, pp.1525-1534, 1989.
DOI : 10.1016/0896-6273(89)90040-8

P. Pechan, T. Yoshida, N. Panahian, M. Moskowitz, and X. Breakefield, Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat, NeuroReport, vol.6, issue.4, pp.669-672, 1995.
DOI : 10.1097/00001756-199503000-00021

I. Semkova, P. Wolz, M. Schilling, and J. Krieglstein, Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage, European Journal of Pharmacology, vol.315, issue.1, pp.19-30, 1996.
DOI : 10.1016/S0014-2999(96)00593-6

Y. Furukawa, [Function, molecular structure and gene expression regulation of nerve growth factor], Nippon Rinsho, vol.50, pp.1910-1917, 1992.

B. Lu, J. Lee, R. Elliott, C. Dreyfus, J. Adler et al., Regulation of NGF gene expression in CNS glia by cell-cell contact, Molecular Brain Research, vol.11, issue.3-4, pp.359-362, 1991.
DOI : 10.1016/0169-328X(91)90046-Z

B. Oderfeld-nowak, A. Bacia, M. Gradkowska, M. Fusco, G. Vantini et al., In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules, Neurochemistry International, vol.21, issue.3, pp.455-461, 1992.
DOI : 10.1016/0197-0186(92)90197-Y

T. Arendt, M. Bruckner, S. Pagliusi, and T. Krell, Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury???I. Degeneration and plastic response of basal forebrain neurons, Neuroscience, vol.65, issue.3, pp.633-645, 1995.
DOI : 10.1016/0306-4522(94)00526-B

M. Carman-krzan, X. Vige, and B. Wise, Regulation by Interleukin-1 of Nerve Growth Factor Secretion and Nerve Growth Factor mRNA Expression in Rat Primary Astroglial Cultures, Journal of Neurochemistry, vol.6, issue.2, pp.636-643, 1991.
DOI : 10.1016/0165-0173(87)90008-7

M. Lipnik-stangelj, D. Juric, and M. Carman-krzan, Histamine-induced synthesis and secretion of nerve growth factor from astrocytes, Inflamm Res, pp.47-81, 1998.

D. Juric and M. Carman-krzan, Cytokine-regulated secretion of nerve growth factor from cultured rat neonatal astrocytes, Pflugers Arch, vol.440, pp.96-98, 2000.

X. Vige, E. Costa, and B. Wise, Mechanism of nerve growthfactor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes, Mol Pharmacol, vol.40, pp.186-192, 1991.

M. Carman-krzan and B. Wise, Arachidonic acid lipoxygenation may mediate interleukin-1 stimulation of nerve growth factor secretion in astroglial cultures, Journal of Neuroscience Research, vol.569, issue.2, pp.225-232, 1993.
DOI : 10.1002/jnr.490340210

L. Vitkovic, J. Bockaert, and J. C. , ???Inflammatory??? Cytokines, Journal of Neurochemistry, vol.52, issue.2, pp.457-471, 2000.
DOI : 10.1046/j.1471-4159.2000.740457.x

W. Griffin, L. Stanley, C. Ling, L. White, V. Macleod et al., Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc Natl Acad Sci, vol.3, issue.86, pp.7611-7615, 1989.

N. Rothwell, Functions and mechanisms of interleukin 1 in the brain, Trends in Pharmacological Sciences, vol.12, pp.430-436, 1991.
DOI : 10.1016/0165-6147(91)90623-Z

T. Liu, P. Mcdonnell, P. Young, R. White, A. Siren et al., Interleukin-1 beta mRNA expression in ischemic rat cortex, Stroke, vol.24, issue.11, pp.1746-1750, 1993.
DOI : 10.1161/01.STR.24.11.1746

G. Mehlhorn, M. Hollborn, and R. Schliebs, Induction of cytokines in glial cells surrounding cortical ??-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology, International Journal of Developmental Neuroscience, vol.18, issue.4-5, pp.423-431, 2000.
DOI : 10.1016/S0736-5748(00)00012-5

P. Mukherjee and G. Pasinetti, Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase???3, Journal of Neurochemistry, vol.270, issue.1, pp.43-49, 2001.
DOI : 10.1046/j.1471-4159.2001.00167.x

H. Osaka, P. Mukherjee, P. Aisen, and G. Pasinetti, Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity, Journal of Cellular Biochemistry, vol.27, issue.3, pp.303-311, 1999.
DOI : 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2

K. Heese, C. Hock, and U. Otten, Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells, Journal of Neurochemistry, vol.70, issue.2, pp.699-707, 1998.
DOI : 10.1046/j.1471-4159.1998.70020699.x

A. Ischenko, S. Sayah, C. Patte, S. Andreev, P. Gasque et al., Expression of a Functional Anaphylatoxin C3a Receptor by Astrocytes, Journal of Neurochemistry, vol.71, issue.6, pp.2487-2496, 1998.
DOI : 10.1046/j.1471-4159.1998.71062487.x

T. Monsinjon, P. Gasque, A. Ischenko, and M. Fontaine, C3A binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8, FEBS Letters, vol.383, issue.3, pp.339-346, 2001.
DOI : 10.1016/S0014-5793(00)02320-6

S. Sayah, C. Patte, P. Gasque, P. Chan, A. Ischenko et al., Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes, Molecular Brain Research, vol.48, issue.2, pp.215-222, 1997.
DOI : 10.1016/S0169-328X(97)00094-6

P. Gasque, P. Chan, M. Fontaine, A. Ischenko, M. Lamacz et al., Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes, J Immunol, vol.155, pp.4882-4889, 1995.

P. Gasque, S. Singhrao, J. Neal, P. Wang, S. Sayah et al., The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis, J Immunol, vol.160, pp.3543-3554, 1998.

S. Sayah, A. Ischenko, A. Zhakhov, A. Bonnard, and M. Fontaine, Expression of Cytokines by Human Astrocytomas Following Stimulation by C3a and C5a Anaphylatoxins, Journal of Neurochemistry, vol.86, issue.6
DOI : 10.1046/j.1471-4159.1999.0722426.x

A. Jauneau, A. Ischenko, P. Chan, and M. Fontaine, Complement component anaphylatoxins upregulate chemokine expression by human astrocytes, FEBS Letters, vol.166, issue.1-3, pp.17-22, 2003.
DOI : 10.1016/S0014-5793(03)00060-7

J. Norgauer, G. Dobos, E. Kownatzki, C. Dahinden, R. Burger et al., Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein, European Journal of Biochemistry, vol.324, issue.1, pp.289-294, 1993.
DOI : 10.1038/351033a0

T. Rollins, S. Siciliano, S. Kobayashi, D. Cianciarulo, V. Bonilla-argudo et al., Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex., Proceedings of the National Academy of Sciences, vol.88, issue.3, pp.971-976, 1991.
DOI : 10.1073/pnas.88.3.971

J. Van-beek, N. O. Ali, C. Ischenko, A. Mackenzie, E. Buisson et al., Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death, Neuroreport, vol.12, issue.2, pp.289-293, 2001.
DOI : 10.1097/00001756-200102120-00022

H. Akiyama, T. Yamada, T. Kawamata, and P. Mcgeer, Association of amyloid P component with complement proteins in neurologically diseased brain tissue, Brain Research, vol.548, issue.1-2, pp.349-352, 1991.
DOI : 10.1016/0006-8993(91)91148-T

P. Mcgeer and E. Mcgeer, Anti-Inflammatory Drugs in the Fight against Alzheimer's Diseasea, Annals of the New York Academy of Sciences, vol.15, issue.1, pp.213-220, 1996.
DOI : 10.1111/j.1749-6632.1996.tb34421.x

R. Gadient, K. Cron, and U. Otten, Interleukin-1 ?? and tumor necrosis factor-?? synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes, Neuroscience Letters, vol.117, issue.3, pp.335-340, 1990.
DOI : 10.1016/0304-3940(90)90687-5

I. Farkas, L. Baranyi, Z. Liposits, T. Yamamoto, and H. Okada, Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells, Neuroscience, vol.86, issue.3, pp.903-911, 1998.
DOI : 10.1016/S0306-4522(98)00108-0

I. Farkas, L. Baranyi, M. Takahashi, A. Fukuda, Z. Liposits et al., A neuronal C5a receptor and an associated apoptotic signal transduction pathway, The Journal of Physiology, vol.272, issue.3, pp.679-687, 1998.
DOI : 10.1111/j.1469-7793.1998.679bs.x

P. Mukherjee and G. Pasinetti, The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer???s disease, Journal of Neuroimmunology, vol.105, issue.2, pp.124-130, 2000.
DOI : 10.1016/S0165-5728(99)00261-1

G. Pasinetti, G. Tocco, S. Sakhi, W. Musleh, M. Desimoni et al., Hereditary Deficiencies in Complement C5 Are Associated with Intensified Neurodegenerative Responses That Implicate New Roles for the C-System in Neuronal and Astrocytic Functions, Neurobiology of Disease, vol.3, issue.3, pp.197-204, 1996.
DOI : 10.1006/nbdi.1996.0020

G. Tocco, W. Musleh, S. Sakhi, S. Schreiber, M. Baudry et al., Complement and glutamate neurotoxicity, Molecular and Chemical Neuropathology, vol.122, issue.3, pp.289-300, 1997.
DOI : 10.1007/BF02815131

D. Mastellos and J. Lambris, Complement: more than a 'guard' against invading pathogens? Trends Immunol, pp.485-491, 2002.